Status:
COMPLETED
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
Lead Sponsor:
Hong Kong Sanatorium & Hospital
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then...
Detailed Description
Achieved serum samples of the different testing groups are retrieved and tested with the immunoassays according to manufacturer's instruction. The test results are then compared and analyzed with sta...
Eligibility Criteria
Inclusion
- Inclusion criteria for COVID-19 infected sera: any patient with PCR confirmed COVID-19 infection
- Inclusion criteria for COVID-19 negative sera: sera collected after a negative SARS-CoV-2 PCR
- Exclusion Criteria:
- \-
Exclusion
Key Trial Info
Start Date :
July 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04496141
Start Date
July 27 2020
End Date
August 31 2020
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Kong Sanatorium & Hospital
Hong Kong, Hong Kong